<DOC>
	<DOCNO>NCT01712100</DOCNO>
	<brief_summary>The objective study prove bioequivalence Roxane Laboratories ' Irbesartan 300 mg Tablets feed condition .</brief_summary>
	<brief_title>Crossover Bioequivalence Study Irbesartan 300 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Irbesartan</mesh_term>
	<criteria>1 . Male female subject age 18 45 year ( inclusive ) . 2 . Voluntary consent participate study . 3 . Body Mass Index ( BMI ) 18 30 ( inclusive ) . 4 . Female subject childbearing potential — surgically sterile least 2 year postmenopausal — must agree utilize one follow form contraception screen completion study : abstinence , hormonal ( oral , implant , transdermal , injection ) least 3 month prior first dose study , barrier ( condom spermicide , diaphragm spermicide ) , IUD , vasectomize partner ( 6 month minimum ) . 5 . No clinically significant abnormal finding physical examination , medical history , clinical laboratory result screen . 1 . A history clinically significant gastrointestinal , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic , psychiatric , cardiovascular disease condition , opinion Investigator , would jeopardize safety subject impact validity study result . 2 . A history allergic adverse response Irbesartan , comparable similar product . 3 . Subjects ( whatever reason ) abnormal diet substantial change eat habit within 30 day prior study initiation . 4 . Subjects must make blood donation one pint within 30 day prior study initiation . 5 . Subjects must make plasma donation within 14 day study initiation . 6 . Participation clinical trial within 30 day prior study initiation . 7 . Use overthecounter ( OTC ) medication , include vitamin , herbal product , dietary supplement , within 7 day prior study . 8 . Use prescription medication within 7 day prior study , exception hormonal contraceptive woman childbearing potential , hormone replacement therapy . 9 . Treatment known enzyme alter drug barbiturate , phenothiazine , cimetidine , carbamazepine , phenytoin , rifampin , rifabutin , glucocorticoid , diltiazem , ketoconazole , MAOI , antidepressant , neuroleptic , verapamil , quinidine , erythromycin , etc. , within 30 day prior study . 10 . Smoking use tobacco product within 6 month prior study . 11 . Female subject lactate . 12 . Positive serum pregnancy test female subject . 13 . Positive blood screen HIV , Hepatitis B Hepatitis C. 14 . Positive screen alcohol drug abuse , history presence alcoholism drug abuse within 6 month prior study start .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>